OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Britta Lipinski, Paul Arras, Lukas Pekar, et al.
Protein Science (2023) Vol. 32, Iss. 3
Open Access | Times Cited: 15
Showing 15 citing articles:
Development of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 315-331
Open Access | Times Cited: 42
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 315-331
Open Access | Times Cited: 42
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Natural killer cell engagers for cancer immunotherapy
Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Frontiers in Oncology (2025) Vol. 14
Open Access
Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Frontiers in Oncology (2025) Vol. 14
Open Access
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition
Britta Lipinski, Laura Unmuth, Paul Arras, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Britta Lipinski, Laura Unmuth, Paul Arras, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
An engineered NKp46 antibody for construction of multi-specific NK cell engagers
Robert Lee, Sainiteesh Maddineni, Madeleine Landry, et al.
Protein Engineering Design and Selection (2024) Vol. 37
Closed Access | Times Cited: 2
Robert Lee, Sainiteesh Maddineni, Madeleine Landry, et al.
Protein Engineering Design and Selection (2024) Vol. 37
Closed Access | Times Cited: 2
Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format
Desislava Yanakieva, Lena Vollmer, Andreas Evers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Desislava Yanakieva, Lena Vollmer, Andreas Evers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Development of a c-MET x CD137 bispecific antibody for targeted immune agonism in cancer immunotherapy
Hong Zhang, Qun Wang, Sireesha Yalavarthi, et al.
Cancer Treatment and Research Communications (2024) Vol. 39, pp. 100805-100805
Open Access | Times Cited: 1
Hong Zhang, Qun Wang, Sireesha Yalavarthi, et al.
Cancer Treatment and Research Communications (2024) Vol. 39, pp. 100805-100805
Open Access | Times Cited: 1
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality
Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1
Monica L. Fernández‐Quintero, Enrico Guarnera, Djordje Müsil, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 1
Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC
Feifei Li, Youyang Shi, Mei Ma, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 10, pp. 100977-100977
Open Access
Feifei Li, Youyang Shi, Mei Ma, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 10, pp. 100977-100977
Open Access
Conditional activation of NK cell function using chemically synthetic constrained bicyclic peptides directed against NKp46 and tumor-expressed antigens
Fay J. Dufort, Christopher J. Leitheiser, Alexandra Rezvaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Fay J. Dufort, Christopher J. Leitheiser, Alexandra Rezvaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhancing NK cell-mediated tumor killing of B7-H6 positive cells with bispecific antibodies targeting allosteric sites of NKp30
Léxane Fournier, Paul Arras, Lukas Pekar, et al.
Deleted Journal (2024) Vol. 33, Iss. 1, pp. 200917-200917
Closed Access
Léxane Fournier, Paul Arras, Lukas Pekar, et al.
Deleted Journal (2024) Vol. 33, Iss. 1, pp. 200917-200917
Closed Access
Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries
Harald Kolmar, Julius Grzeschik, Doreen Könning, et al.
Methods in molecular biology (2023), pp. 227-243
Closed Access | Times Cited: 1
Harald Kolmar, Julius Grzeschik, Doreen Könning, et al.
Methods in molecular biology (2023), pp. 227-243
Closed Access | Times Cited: 1
